Full Professor in Biochemistry and Molecular Biology and leader of the research group on Gene Therapy for Neurometabolic Diseases at the Institute of Neurosciences at the Universitat Autònoma of Barcelona. Assumpció Bosch obtained her PhD in 1994 (UAB) and did her postdoctoral training on gene therapy strategies using viral vectors was done in Beverly Davidson’s (University of Iowa, USA) and Jean Michel Heard’s laboratories (Pasteur Institute, Paris, France) from 1995 to 2000, after which she returned to Barcelona. She was awarded with a Ramon y Cajal tenure track in its first call (2002) and she moved to the UAB, starting her own research group in 2005 at CBATEG on Gene therapy strategies for neuropathies. In 2006 she was appointed as Associate Professor at the Department of Biochemistry and Molecular Biology, where she has acted as Director of the Master’s Degree and PhD programs in Biochemistry, Molecular Biology and Biomedicine (2011-2014) and as Deputy Director of the Department (2014-2020). She currently serves as Director of the Department of Biochemistry and Molecular Biology. She has published more than 70 peer-reviewed articles and directed national and European funded research projects. She is a reviewer for several national and international funding agencies and scientific journals. Her research activity is focused on the development of gene therapy strategies for diseases affecting the nervous system, both central (lysosomal storage diseases, ALS, megalencephalic leukodystrophy) and peripheral (pain, genetic and acquired neuropathies) and on the elucidation of the molecular mechanisms implicated in the development of these pathologies combining the use of animal models, tissue cell culture and viral vectors.